Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Esther Saunders-Jennings"'
Autor:
Alfie R. Wearn, Esther Saunders-Jennings, Volkan Nurdal, Emma Hadley, Michael J. Knight, Margaret Newson, Risto A. Kauppinen, Elizabeth J. Coulthard
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-9 (2020)
Abstract Background Here, we address a pivotal factor in Alzheimer’s prevention—identifying those at risk early, when dementia can still be avoided. Recent research highlights an accelerated forgetting phenotype as a risk factor for Alzheimer’s
Externí odkaz:
https://doaj.org/article/c0629d0866cd4c52b30c8136d4922930
Autor:
Alfie R. Wearn, Volkan Nurdal, Esther Saunders-Jennings, Michael J. Knight, Hanna K. Isotalus, Serena Dillon, Demitra Tsivos, Risto A. Kauppinen, Elizabeth J. Coulthard
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2020)
Abstract Background Early Alzheimer’s disease (AD) diagnosis is vital for development of disease-modifying therapies. Prior to significant brain tissue atrophy, several microstructural changes take place as a result of Alzheimer’s pathology. Thes
Externí odkaz:
https://doaj.org/article/fac9fb199eca4558b1f6aa3f07c85b88
Autor:
Alfie R. Wearn, Volkan Nurdal, Esther Saunders-Jennings, Michael J. Knight, Christopher R. Madan, Sean-James Fallon, Hanna K. Isotalus, Risto A. Kauppinen, Elizabeth J. Coulthard
Publikováno v:
NeuroImage, Vol 238, Iss , Pp 118214- (2021)
A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructur
Externí odkaz:
https://doaj.org/article/a5bdcccec8ff4f3e826402421b5b6e00
Autor:
Margaret Newson, Alfie Wearn, Michael J. Knight, Esther Saunders-Jennings, Emma Hadley, Elizabeth Coulthard, Volkan Nurdal, Risto A. Kauppinen
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-9 (2020)
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy
Background Here, we address a pivotal factor in Alzheimer’s prevention—identifying those at risk early, when dementia can still be avoided. Recent research highlights an accelerated forgetting phenotype as a risk factor for Alzheimer’s disease.
Autor:
Hanna K. Isotalus, Christopher R. Madan, Volkan Nurdal, Alfie Wearn, Risto A. Kauppinen, Elizabeth Coulthard, Esther Saunders-Jennings, Sean-James Fallon, Michael J. Knight
Publikováno v:
Wearn, A R, Nurdal, V, Saunders-Jennings, E, Knight, M J, Madan, C R, Fallon, S-J, Isotalus, H K, Kauppinen, R A & Coulthard, E J 2021, ' T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment ', NeuroImage, vol. 238, 118214 . https://doi.org/10.1016/j.neuroimage.2021.118214
Neuroimage
NeuroImage, Vol 238, Iss, Pp 118214-(2021)
Neuroimage
NeuroImage, Vol 238, Iss, Pp 118214-(2021)
A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c95e8c0e9239092665c17e0e090842
https://hdl.handle.net/1983/a3ee033e-f026-46ae-8026-2dbddb3f1bb2
https://hdl.handle.net/1983/a3ee033e-f026-46ae-8026-2dbddb3f1bb2
Autor:
Michael J. Knight, Alfie Wearn, Hanna K. Isotalus, Christopher R. Madan, Elizabeth Coulthard, Esther Saunders-Jennings, Sean-James Fallon, Risto A. Kauppinen, Volkan Nurdal
A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer’s disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstruct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fb7c890865af6e9ba93c67654d35168
https://doi.org/10.1101/2020.11.03.20225177
https://doi.org/10.1101/2020.11.03.20225177
Autor:
Risto A. Kauppinen, Michael J. Knight, Alfie Wearn, Esther Saunders-Jennings, Demitra Tsivos, Volkan Nurdal, Elizabeth Coulthard, Hanna K. Isotalus, Serena Dillon
Publikováno v:
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2020)
Wearn, A R, Nurdal, V, Saunders-Jennings, E, Knight, M J, Isotalus, H K, Dillon, S, Tsivos, D, Kauppinen, R A & Coulthard, E J 2020, ' T2 heterogeneity : a novel marker of microstructural integrity associated with cognitive decline in people with mild cognitive impairment ', Alzheimer's Research and Therapy, vol. 12, 105 (2020) . https://doi.org/10.1186/s13195-020-00672-9
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2020)
Wearn, A R, Nurdal, V, Saunders-Jennings, E, Knight, M J, Isotalus, H K, Dillon, S, Tsivos, D, Kauppinen, R A & Coulthard, E J 2020, ' T2 heterogeneity : a novel marker of microstructural integrity associated with cognitive decline in people with mild cognitive impairment ', Alzheimer's Research and Therapy, vol. 12, 105 (2020) . https://doi.org/10.1186/s13195-020-00672-9
Background Early Alzheimer’s disease (AD) diagnosis is vital for development of disease-modifying therapies. Prior to significant brain tissue atrophy, several microstructural changes take place as a result of Alzheimer’s pathology. These include
Autor:
Risto A. Kauppinen, Serena Dillon, Hanna K. Isotalus, Michael J. Knight, Alfie Wearn, Esther Saunders-Jennings, Elizabeth Coulthard, Demitra Tsivos, Volkan Nurdal
Early Alzheimer’s disease diagnosis is vital for development of disease-modifying therapies. Prior to significant loss of brain tissue, several microstructural changes take place as a result of Alzheimer’s pathology. These include deposition of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e4eb36f16ff439b24ed56e17f4e305
https://doi.org/10.1101/2020.05.13.20100339
https://doi.org/10.1101/2020.05.13.20100339